Acrivon Therapeutics, Inc. (ACRV)
1.60
-0.03
(-1.84%)
USD |
NASDAQ |
May 29, 16:00
1.615
+0.02
(+0.94%)
After-Hours: 20:00
Acrivon Therapeutics EPS Diluted (Quarterly) : -0.4917 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
| Vericel Corp. | -0.1241 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.04M |
| Total Expenses (Quarterly) | 19.04M |
| Enterprise Value | -26.84M |
| Earnings Yield | -125.1% |
| Normalized Earnings Yield | -125.11 |